Clinical Trial: A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107230) titled 'A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors' on Aug. 05.

Brief Summary: The purpose of this study is to determine recommended phase 2 doses (RP2Ds) of JNJ-95437446 in Part 1, and to further evaluate the safety of the RP2Ds in participants with advanced solid tumors in Part 2.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Colorectal Neoplasms

Intervention: DRUG: JNJ-95437446

JNJ-95437446 will be administered.

Recruitment Status: RECRUITING

Sponsor: Janssen Research & Development, LLC

Disclaimer: Curated by HT Syndication....